Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Company Profile for Health Discovery Corporation.


Health Discovery Corporation (OTCBB OTCBB

See OTC Bulletin Board (OTCBB).
:HDVY) has become the first company to perform the total process of identifying a particular clinical medical problem to be solved and performing the entire process leading to the identification of the genes or proteins (biomarkers) and the relationships among them (pathways) that are relevant to the solution of the medical problem.
Company:                Health Discovery Corporation

   Headquarters Address:   6709 Waters Avenue
                           Savannah, Georgia 31406

   Main Telephone:         800-965-3198

   Website:                http://www.healthdiscoverycorp.com

   Ticker:                 (OTCBB:HDVY)

   Type of Organization:   Public

   Industry:               Health

   Key Executives:         CEO: Stephen Barnhill
                           President: David Cooper
                           Chief Administrative Officer:
                            Robert Braswell

   CEO
     Contact:              Stephen Barnhill
     Phone:                800-965-3198
     Email:                barnhillmd@sprynet.com
COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jul 15, 2005
Words:108
Previous Article:Company Profile for Spirit Airlines.
Next Article:Company Profile for Cerebit Security Applications.
Topics:



Related Articles
Wyeth-Ayerst Research and Gene Logic Initiate First Preclinical Toxicity Application of Genomic Gene Expression Technology.
Celera and Paradigm Genetics Enter Strategic Alliance to Offer Genomic Technologies to the Plant-based Agricultural Industry.
Paradigm Genetics Announces 4Q01/Year End Earnings Conference Call; Thursday, February 28, 2002, at 8:30 a.m. EST.
Paradigm Genetics Announces Q102 Earnings Conference Call; Thursday, May 2, 2002, at 8:30 a.m. ET.
SMALL SCREEN.
Metabolic profiling: application to toxicology and risk reduction.
Plexxikon Signs Broad Kinase Screening Collaboration With Invitrogen.
UPSTATE GROUP/CXR BIOSCIENCES DEVELOPING IN VITRO SCREENS.
Invitrogen and Emiliem Sign Major Kinase Screening Agreement.
New Collaboration Intended to Advance Drug Discovery Methods.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles